Resumen
DISRUPT aims at revolutionising the field of biomedical imaging by developing a radically new
lab-a-on-chip technology: integrated tomographic microscopy. This unprecedented technique will be
enabled by pushing forward the science of on-chip wireless photonics and tomography, in combination
with microfluidics and artificial intelligence (AI). The CMOS compatibility of this technology
represents a paradigm shift as it assures the realization of tomographic microscopes that are
dramatically cheaper, lighter, and smaller than current approaches. Moreover, the singular features
of the proposed solution introduce key advantages in terms of resolution, sensitivity, throughput,
parallelisation, and energy efficiency. To illustrate its potential, we will show that on-chip TPM
can be used for cancer detection and the identification of infected cells. Developments related to
fundamental nanoantenna and diffraction tomography science, nanophotonics, nanofabrication,
microfluidics, AI and clinical validation will be undertaken by a consortium comprised by 2 SME, 1
HE, 1 Non-profit RO and 2 Cancer R&D Medical institutions, with complementary expertise, leaders in
their respective markets and R&D fields. This novel device is suited for many applications, such as
early cancer diagnosis, cell characterisation, research on cancer and infectious diseases,
immunocyte phenotyping, stem cell multipotency identification, tissue pathology, haematopathology,
and analysis of infected cells. Its intrinsic mass-producible, compact, low-cost, mechanically
robust, and energy-efficient feature makes this technology a future innovation driver for new
developments in many biomedical application fields, and offers an alternative toolset addressing
some
low-resource settings, telemedicine applications and point-of-care,
aving a potentially huge societal impact fostering early diagnosis of cancer and other diseases and
infections.
